Boston Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	20,074	16,747	14,240	12,682	11,888
Revenue Growth (YoY)	19.87%	17.61%	12.29%	6.68%	19.92%
Cost of Revenue	6,221	5,257	4,345	3,956	3,711
Gross Profit	13,854	11,490	9,896	8,727	8,177
Selling, General & Admin	6,887	5,984	5,190	4,520	4,359
Depreciation & Amortization Expenses	897	856	828	803	741
Research & Development	2,052	1,615	1,414	1,323	1,204
Other Operating Expenses	405	430	120	433	675
Total Operating Expenses	10,241	8,885	7,552	7,079	6,979
Operating Income	3,613	2,603	2,343	1,649	1,199
Interest Expense	-349	-305	-265	-470	-341
Other Non-Operating Income (Expense)	121	-16	-93	-38	218
Total Non-Operating Income (Expense)	-228	-321	-358	-508	-123
Pretax Income	3,385	2,282	1,985	1,141	1,076
Provision for Income Taxes	493	436	393	443	36
Net Income	2,898	1,853	1,570	642	985
Minority Interest in Earnings	-6	-8	-1	-	-
Net Income Attributable to Preferred Dividends	-	-	23	55	55
Net Income to Common	2,898	1,853	1,570	642	985
Net Income Growth	56.39%	18.02%	144.55%	-34.82%	-
Shares Outstanding (Basic)	1,480	1,472	1,453	1,431	1,431
Shares Outstanding (Diluted)	1,495	1,486	1,464	1,440	1,442
Shares Change (YoY)	0.58%	1.53%	1.65%	-0.16%	1.79%
EPS (Basic)	1.96	1.26	1.08	0.45	0.72
EPS (Diluted)	1.94	1.25	1.07	0.45	0.72
EPS Growth	55.20%	16.82%	137.78%	-37.50%	-
Shares Outstanding	1,483	1,475	1,465	1,433	1,425
Free Cash Flow	3,658	2,645	1,792	938	1,316
Free Cash Flow Growth	38.30%	47.60%	91.05%	-28.72%	16.25%
Free Cash Flow Per Share	2.45	1.78	1.22	0.65	0.91
Gross Margin	69.01%	68.61%	69.49%	68.81%	68.78%
Operating Margin	18.00%	15.54%	16.45%	13.00%	10.09%
Profit Margin	14.41%	11.02%	11.18%	5.50%	8.75%
FCF Margin	18.22%	15.79%	12.58%	7.40%	11.07%
EBITDA	4,981	3,872	3,539	2,785	2,292
EBITDA Margin	24.81%	23.12%	24.85%	21.96%	19.28%
EBIT	3,613	2,603	2,343	1,649	1,199
EBIT Margin	18.00%	15.54%	16.45%	13.00%	10.09%
Effective Tax Rate	14.56%	19.11%	19.80%	38.83%	3.35%

Updated Feb 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q